Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and immunoadsorption for ABO-incompatible liver transplantation (pilot study)
2007-007545-13Phase 2Terminated
- Sponsor
- Sahlgrenska University Hospital
- Start
- Dec 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of rituximab in hepatic failure (2 arms), sponsored by Sahlgrenska University Hospital. Primary endpoints: Composite endpoint at 3 months and Composite endpoint at 12 months. Started Dec 2008; status: terminated.
02
Drugs
rituximab
03
Conditions
hepatic failure
Beyond the preview
Go deeper on 2007-007545-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007545-13.